Comparison of critical drug-drug interaction listings: The department of veterans affairs medical system and standard reference compendia

Clinical Pharmacology and Therapeutics

Volumn 87, Issue 1, 2010, Pages 48-51

  Olvey, E L ^a   Clauschee, S ^b   Malone, D C ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b INDIAN HEALTH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CIMETIDINE; CIPROFLOXACIN; CISAPRIDE; CLARITHROMYCIN; DELAVIRDINE; DICOUMAROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETHINYLESTRADIOL; ITRACONAZOLE; KETOCONAZOLE; NEUROLEPTIC AGENT; PHENYTOIN; RIFAMPICIN; WARFARIN;

ARTICLE; CONTROLLED STUDY; DRUG LEGISLATION; GOVERNMENT; HEALTH CARE SYSTEM; HUMAN; INTERMETHOD COMPARISON; MICROMEDEX DRUG REAX; PRIORITY JOURNAL; SCORING SYSTEM; STANDARD; UNITED STATES; VETERAN;

DRUG INFORMATION SERVICES; DRUG INTERACTIONS; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOPOEIAS AS TOPIC; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 72849125569     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.198     Document Type: Article

References (14)

1. Juurlink, D.N., Mamdani, M., Kopp, A., Laupacis, A. & Redelmeier, D.A. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289, 1652-1658 (2003).
2. Zhan, C. et al. Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drug-disease combinations. J. Am. Geriatr. Soc. 53, 262-267 (2005).
3. Mahmood, M. et al. Potential drug-drug interactions within Veterans afairs medical centers. Am. J. Health. Syst. Pharm. 64, 1500-1505 (2007).
4. Kohn, L.T., Corrigan, J.M. & Donaldson, M.S. (eds.); Committee on Quality of Health Care in america, Institute of Medicine. To Err Is Human: Building a Safer Health System (National academy Press, Washington, DC, 1999).
5. Fulda, T.R., Valuck, R.J., Zanden, V.J., Parker, S. & Byrns, P.J. Disagreement among drug compendia on inclusion and ratings of drug-drug interactions. Curr. Ther. Res. Clin. Exp. 61, 540-548 (2000).
6. Abarca, J. et al. Concordance of severity ratings provided in four drug interaction compendia. J. Am. Pharm. Assoc. (2003) 44, 136-141 (2004).
7. Vitry, A.I. Comparative assessment of four drug interaction compendia. Br. J. Clin. Pharmacol. 63, 709-714 (2007).
8. Chao, S.D. & Maibach, H.I. Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugs. Am. J. Clin. Dermatol. 6, 105-111 (2005).
9. Wong, C.M., Ko, Y. & Chan, A. Clinically signifcant drug-drug interactions between oral anticancer agents and nonanticancer agents: profling and comparison of two drug compendia. Ann. Pharmacother. 42, 1737-1748 (2008).
10. Grizzle, A.J. et al. Reasons provided by prescribers when overriding drug-drug interaction alerts. Am. J. Manag. Care 13, 573-578 (2007).
11. Ko, Y. et al. Practitioners' views on computerized drug-drug interaction alerts in the Va system. J. Am. Med. Inform. Assoc. 14, 56-64 (2007).
12. DRUG-REaX System [internet database]. Greenwood Village, CO: Thomson Reuters (Healthcare), 2009.
13. Hansten, P.D. & Horn, J.R. Drug Interactions: Analysis and Management (Facts and Comparisons, St Louis, MO, 2007).
14. Cohen, J. a coefcient of agreement for nominal scales. Educ. Psychol. Meas. 20, 37-46 (1960).